Checking in on Kymera Therapeutics Inc (KYMR) after recent insiders movement

In a filing, Kymera Therapeutics Inc revealed its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar 15 ’24. In the deal valued at $40.46 per share,71,764 shares were sold. As a result of this transaction, Booth Bruce now holds 806,697 shares worth roughly $31.86 million. Then, Booth Bruce sold 55,779 shares, […]

Sharp decrease in KYMR’s short interest leads to decline in days-to-cover ratio

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kymera Therapeutics Inc shares valued at $2,903,336 were sold by Booth Bruce on Mar 15 ’24. At $40.46 per share, Booth Bruce sold 71,764 shares. The insider’s holdings dropped to 806,697 shares worth approximately […]

Examining the Potential Price Growth of Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc’s recently made public that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar 15 ’24. In the deal valued at $40.46 per share,71,764 shares were sold. As a result of this transaction, Booth Bruce now holds 806,697 shares worth roughly $31.72 million. Then, Booth Bruce sold 55,779 shares, […]

Sharp decrease in KYMR’s short interest leads to decline in days-to-cover ratio

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kymera Therapeutics Inc shares valued at $5,880,415 were sold by Booth Bruce on Mar 13 ’24. At $42.23 per share, Booth Bruce sold 139,255 shares. The insider’s holdings dropped to 828,830 shares worth approximately […]

Analysts review Kymera Therapeutics Inc’s rating

Kymera Therapeutics Inc’s recently made public that its Chief Financial Officer Jacobs Bruce N. unloaded Company’s shares for reported $0.16 million on Mar 04 ’24. In the deal valued at $41.86 per share,3,934 shares were sold. As a result of this transaction, Jacobs Bruce N. now holds 142,351 shares worth roughly $6.02 million. Then, Gollob […]

KYMR short interest declines, indicating growing optimism among investors

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Kymera Therapeutics Inc shares valued at $164,664 were sold by Jacobs Bruce N. on Mar 04 ’24. At $41.86 per share, Jacobs Bruce N. sold 3,934 shares. The insider’s holdings dropped […]

Kymera Therapeutics Inc (KYMR) receives a Peer perform rating from Wolfe Research

Kymera Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Jacobs Bruce N. unloaded Company’s shares for reported $0.16 million on Mar 04. In the deal valued at $41.86 per share,3,934 shares were sold. As a result of this transaction, Jacobs Bruce N. now holds 142,351 shares worth roughly $6.06 million. Then, Gollob Jared […]

KYMR Shares Experience Decline in Value

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kymera Therapeutics Inc shares valued at $171,227 were sold by Albers Jeffrey W. on Feb 21. At $39.05 per share, Albers Jeffrey W. sold 4,385 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following […]

Kymera Therapeutics Inc (KYMR) receives a Peer perform rating from Wolfe Research

NUE

Kymera Therapeutics Inc’s filing revealed that its Director Albers Jeffrey W. unloaded Company’s shares for reported $0.17 million on Feb 21. In the deal valued at $39.05 per share,4,385 shares were sold. As a result of this transaction, Albers Jeffrey W. now holds 0 shares worth roughly $0.0. Then, Albers Jeffrey W. sold 615 shares, […]